{
  "api_version": "1",
  "request": {
    "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Atrophy%2C+Muscular&page=13",
    "query": {
      "condition": "Atrophy, Muscular",
      "page": 13
    },
    "page_size": 10
  },
  "pagination": {
    "page": 13,
    "page_size": 10,
    "total_count": 847,
    "total_pages": 85,
    "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Atrophy%2C+Muscular&page=14&page_size=10",
    "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Atrophy%2C+Muscular&page=12&page_size=10"
  },
  "source": "remote",
  "last_synced_at": "2026-10-24T00:48:01.843Z",
  "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.",
  "notes": [
    "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.",
    "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.",
    "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees."
  ],
  "trials": [
    {
      "nct_id": "NCT01403402",
      "title": "Congenital Muscle Disease Study of Patient and Family Reported Medical Information",
      "overall_status": "RECRUITING",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency",
        "Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy and Abnormal Glycosylation of Dystroglycan With Severe Epilepsy)",
        "Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Fatty Liver and Infantile-onset Cataract Caused by TRAPPC11 Mutations)",
        "Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Hypoglycosylation of Dystroglycan)",
        "Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Hypoglycosylation of Dystroglycan and Epilepsy)",
        "Alpha-Dystroglycanopathy (Dystroglycanopathy, Congenital With or Without Mental Retardation (Formerly MDC1C))",
        "Alpha-Dystroglycanopathy (Fukuyama CMD)",
        "Alpha-Dystroglycanopathy (LGMDR09 FKRP Related (Formerly LGMD2I))",
        "Alpha-Dystroglycanopathy (LGMDR11 POMT1 Related (Formerly LGMD2K))",
        "Alpha-Dystroglycanopathy (LGMDR13 FKTN Related (Formerly LGMD2M))",
        "Alpha-Dystroglycanopathy (LGMDR14 POMT2 Related (Formerly LGMD2N))",
        "Alpha-Dystroglycanopathy (LGMDR15 POMGnT1 Related (Formerly LGMD2O))",
        "Alpha-Dystroglycanopathy (LGMDR19 GMPPB Related (Formerly LGMD2T))",
        "Alpha-Dystroglycanopathy (LGMDR20 ISPD Related (Formerly LGMD2U))",
        "Alpha-Dystroglycanopathy (LGMDR24 POMGnT2 Related)",
        "Alpha-Dystroglycanopathy (Muscle Eye Brain Disease (MEB))",
        "Alpha-Dystroglycanopathy (Walker Warburg Syndrome (WWS))",
        "Choline Kinase B Receptor - CHKB",
        "Collagen VI Related Disorders",
        "Collagen XII Related Disorders",
        "Congenital Muscular Dystrophy Not Otherwise Specified (Including Merosin Positive)",
        "Congenital Muscular Dystrophy With Cataracts and Intellectual Disability (MDCCAID)",
        "Congenital Muscular Dystrophy With Joint Hyperlaxity",
        "Congenital Muscular Dystrophy With Rigid Spine Related to ACTA1",
        "Emery-Dreifuss Muscular Dystrophy",
        "GOLGA2-related Congenital Muscle Dystrophy With Brain Involvement",
        "LMNA Related Disorders",
        "Merosin Deficient CMD (Full or Partial)",
        "Nesprin Related MD (SYNE1)",
        "SELENON Related Disorders (Previously Known as SEPN1)",
        "SELENON Related Myopathy (Aka SEPN1)",
        "Telethonin CMD",
        "Congenital Myasthenic Syndrome",
        "Limb-Girdle Muscular Dystrophy",
        "LGMDD01 - DNAJB6 (Formerly LGMD1D)",
        "LGMDD05 - Collagen VI Related Bethlem Myopathy (Dominant)",
        "LGMDR07 - Telethonin (TCAP) Related (Formerly LGMD2G)",
        "LGMDR08 - TRIM Related (Formerly LGMD2H)",
        "LGMDR09 - FKRP Related (Formerly LGMD2I)",
        "LGMDR10 - Titin (TTN) Related (Formerly LGMD2J)",
        "LGMDR11 - POMT1 Related (Formerly LGMD2K)",
        "LGMDR13 - Fukutin (FKTN) Related (Formerly LGMD2M)",
        "LGMDR14 - POMT2 Related (Formerly LGMD2N)",
        "LGMDR15 - POMGnT1 Related (Formerly LGMD2O)",
        "LGMDR16 - DAG1 Related Dystroglycanopathy (Formerly LGMD2P)",
        "LGMDR17 - Plectin (PLEC) Related (Formerly LGMD2Q)",
        "LGMDR18 - TRAPPC11 Related (Formerly LGMD2S)",
        "LGMDR19 - GMPPB Related (Formerly LGMD2T)",
        "LGMDR20 - ISPD Related (Formerly LGMD2U)",
        "LGMDR22 - Collagen VI Related Bethlem Myopathy (Recessive)",
        "LGMDR23 - LAMA2 Related",
        "LGMDR24 - POMGnT2 Related"
      ],
      "interventions": [],
      "intervention_types": [],
      "sponsor": "Cure CMD",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": null,
        "maximum_age": null,
        "sex": "ALL",
        "summary": "Not listed"
      },
      "enrollment_count": 4000,
      "start_date": "2009-09",
      "completion_date": "2029-09",
      "has_results": false,
      "last_update_posted_date": "2021-08-09",
      "last_synced_at": "2026-10-24T00:48:01.843Z",
      "location_count": 1,
      "location_summary": "Lakewood, California",
      "locations": [
        {
          "city": "Lakewood",
          "state": "California"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT01403402"
    },
    {
      "nct_id": "NCT01308957",
      "title": "Fish Oil and Muscle Function",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Sarcopenia"
      ],
      "interventions": [
        {
          "name": "Omega-3 fatty acids",
          "type": "DIETARY_SUPPLEMENT"
        },
        {
          "name": "corn oil",
          "type": "DIETARY_SUPPLEMENT"
        }
      ],
      "intervention_types": [
        "DIETARY_SUPPLEMENT"
      ],
      "sponsor": "Washington University School of Medicine",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "85 Years",
        "sex": "ALL",
        "summary": "18 Years to 85 Years"
      },
      "enrollment_count": 77,
      "start_date": "2011-06",
      "completion_date": "2014-12",
      "has_results": false,
      "last_update_posted_date": "2014-12-10",
      "last_synced_at": "2026-10-24T00:48:01.843Z",
      "location_count": 1,
      "location_summary": "St Louis, Missouri",
      "locations": [
        {
          "city": "St Louis",
          "state": "Missouri"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT01308957"
    },
    {
      "nct_id": "NCT06867107",
      "title": "An Open-label Long-term Follow-up Study of SAT-3247 for Participants With Duchenne Muscular Dystrophy Including Those Who Participated in SAT-3247-CL-101",
      "overall_status": "ENROLLING_BY_INVITATION",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ],
      "conditions": [
        "Duchenne Muscular Dystrophy (DMD)"
      ],
      "interventions": [
        {
          "name": "SAT-3247",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "Satellos Bioscience, Inc.",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "16 Years",
        "maximum_age": "40 Years",
        "sex": "MALE",
        "summary": "16 Years to 40 Years · Male only"
      },
      "enrollment_count": 30,
      "start_date": "2025-08-20",
      "completion_date": "2027-09-30",
      "has_results": false,
      "last_update_posted_date": "2026-10-13",
      "last_synced_at": "2026-10-24T00:48:01.843Z",
      "location_count": 4,
      "location_summary": "Los Angeles, California • St Louis, Missouri • Columbus, Ohio + 1 more",
      "locations": [
        {
          "city": "Los Angeles",
          "state": "California"
        },
        {
          "city": "St Louis",
          "state": "Missouri"
        },
        {
          "city": "Columbus",
          "state": "Ohio"
        },
        {
          "city": "Memphis",
          "state": "Tennessee"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT06867107"
    },
    {
      "nct_id": "NCT02811445",
      "title": "Role of the Gut Microbiome on Lean Mass and Physical Function in Older Adults",
      "overall_status": "COMPLETED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Sarcopenia"
      ],
      "interventions": [],
      "intervention_types": [],
      "sponsor": "Tufts University",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "70 Years",
        "maximum_age": "85 Years",
        "sex": "ALL",
        "summary": "70 Years to 85 Years"
      },
      "enrollment_count": 29,
      "start_date": "2016-05",
      "completion_date": "2019-11-01",
      "has_results": true,
      "last_update_posted_date": "2020-08-06",
      "last_synced_at": "2026-10-24T00:48:01.843Z",
      "location_count": 1,
      "location_summary": "Boston, Massachusetts",
      "locations": [
        {
          "city": "Boston",
          "state": "Massachusetts"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT02811445"
    },
    {
      "nct_id": "NCT05754632",
      "title": "The Impact of Blood Flow Restriction Training in Adolescents After ACL Reconstruction: A Randomized Controlled Trial",
      "overall_status": "RECRUITING",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Anterior Cruciate Ligament Injuries",
        "Knee Injuries",
        "Quadriceps Muscle Atrophy"
      ],
      "interventions": [
        {
          "name": "Blood Flow Restriction using Delfi Personalized Tourniquet System",
          "type": "DEVICE"
        }
      ],
      "intervention_types": [
        "DEVICE"
      ],
      "sponsor": "Connecticut Children's Medical Center",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "12 Years",
        "maximum_age": "18 Years",
        "sex": "ALL",
        "summary": "12 Years to 18 Years"
      },
      "enrollment_count": 40,
      "start_date": "2023-06-08",
      "completion_date": "2029-05-01",
      "has_results": false,
      "last_update_posted_date": "2026-01-07",
      "last_synced_at": "2026-10-24T00:48:01.843Z",
      "location_count": 1,
      "location_summary": "Farmington, Connecticut",
      "locations": [
        {
          "city": "Farmington",
          "state": "Connecticut"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT05754632"
    },
    {
      "nct_id": "NCT00968344",
      "title": "Muscle Mass During Space Exploration",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Muscle Loss"
      ],
      "interventions": [
        {
          "name": "Leucine",
          "type": "DIETARY_SUPPLEMENT"
        },
        {
          "name": "Alanine",
          "type": "DIETARY_SUPPLEMENT"
        }
      ],
      "intervention_types": [
        "DIETARY_SUPPLEMENT"
      ],
      "sponsor": "The University of Texas Medical Branch, Galveston",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "45 Years",
        "maximum_age": "60 Years",
        "sex": "ALL",
        "summary": "45 Years to 60 Years"
      },
      "enrollment_count": 40,
      "start_date": "2009-08",
      "completion_date": "2015-04",
      "has_results": true,
      "last_update_posted_date": "2019-05-31",
      "last_synced_at": "2026-10-24T00:48:01.843Z",
      "location_count": 1,
      "location_summary": "Galveston, Texas",
      "locations": [
        {
          "city": "Galveston",
          "state": "Texas"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00968344"
    },
    {
      "nct_id": "NCT04926181",
      "title": "Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer",
      "overall_status": "TERMINATED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ],
      "conditions": [
        "Small Cell Neuroendocrine Carcinoma",
        "Prostate Cancer",
        "Small Cell Carcinoma"
      ],
      "interventions": [
        {
          "name": "Apalutamide",
          "type": "DRUG"
        },
        {
          "name": "Cetrelimab",
          "type": "BIOLOGICAL"
        }
      ],
      "intervention_types": [
        "DRUG",
        "BIOLOGICAL"
      ],
      "sponsor": "Rahul Aggarwal",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "MALE",
        "summary": "18 Years and older · Male only"
      },
      "enrollment_count": 2,
      "start_date": "2022-03-16",
      "completion_date": "2024-03-31",
      "has_results": true,
      "last_update_posted_date": "2025-05-15",
      "last_synced_at": "2026-10-24T00:48:01.843Z",
      "location_count": 1,
      "location_summary": "San Francisco, California",
      "locations": [
        {
          "city": "San Francisco",
          "state": "California"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT04926181"
    },
    {
      "nct_id": "NCT01489930",
      "title": "Effects of Resistance and Endurance Training on Synthesis of Individual Muscle Proteins in Young and Older Adults",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Sarcopenia"
      ],
      "interventions": [
        {
          "name": "Endurance exercise",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Resistance exercise",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Control/Combined training",
          "type": "BEHAVIORAL"
        }
      ],
      "intervention_types": [
        "BEHAVIORAL"
      ],
      "sponsor": "Mayo Clinic",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 67,
      "start_date": "2008-05",
      "completion_date": "2011-02",
      "has_results": false,
      "last_update_posted_date": "2011-12-12",
      "last_synced_at": "2026-10-24T00:48:01.843Z",
      "location_count": 1,
      "location_summary": "Rochester, Minnesota",
      "locations": [
        {
          "city": "Rochester",
          "state": "Minnesota"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT01489930"
    },
    {
      "nct_id": "NCT03665051",
      "title": "Electrical Stimulation of Human Myocytes in Microgravity",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Sarcopenia"
      ],
      "interventions": [
        {
          "name": "Muscle Tissue Biopsy",
          "type": "PROCEDURE"
        },
        {
          "name": "Maximal Oxygen Consumption (V02max)",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "PROCEDURE",
        "OTHER"
      ],
      "sponsor": "AdventHealth Translational Research Institute",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "20 Years",
        "maximum_age": "80 Years",
        "sex": "ALL",
        "summary": "20 Years to 80 Years"
      },
      "enrollment_count": 75,
      "start_date": "2019-01-25",
      "completion_date": "2025-12",
      "has_results": false,
      "last_update_posted_date": "2025-06-11",
      "last_synced_at": "2026-10-24T00:48:01.843Z",
      "location_count": 1,
      "location_summary": "Orlando, Florida",
      "locations": [
        {
          "city": "Orlando",
          "state": "Florida"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT03665051"
    },
    {
      "nct_id": "NCT04495075",
      "title": "Neuromuscular Control in Individuals Following ACL-Reconstruction",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Anterior Cruciate Ligament Injuries",
        "Quadriceps Muscle Atrophy"
      ],
      "interventions": [
        {
          "name": "Visuomotor Therapy",
          "type": "OTHER"
        },
        {
          "name": "Passive Motion",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "OTHER"
      ],
      "sponsor": "University of Virginia",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "45 Years",
        "sex": "ALL",
        "summary": "18 Years to 45 Years"
      },
      "enrollment_count": 10,
      "start_date": "2019-03-01",
      "completion_date": "2020-03-01",
      "has_results": false,
      "last_update_posted_date": "2020-07-31",
      "last_synced_at": "2026-10-24T00:48:01.843Z",
      "location_count": 1,
      "location_summary": "Charlottesville, Virginia",
      "locations": [
        {
          "city": "Charlottesville",
          "state": "Virginia"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT04495075"
    }
  ]
}